
Uniphos Enterprises (UNIENTER) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
729.0M
Gross Profit
4.3M
0.58%
Operating Income
-17.8M
-2.44%
Net Income
-15.8M
-2.16%
Balance Sheet Metrics
Total Assets
28.4B
Total Liabilities
1.0B
Shareholders Equity
27.4B
Debt to Equity
0.04
Cash Flow Metrics
Revenue & Profitability Trend
Uniphos Enterprises Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 1.1B | 506.5M | 14.7M | 12.2M | 8.3M |
Cost of Goods Sold | 1.1B | 505.5M | 14.6M | 12.1M | 8.3M |
Gross Profit | 8.0M | 1.0M | 164.0K | 123.0K | 75.0K |
Gross Margin % | 0.7% | 0.2% | 1.1% | 1.0% | 0.9% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 6.0M | 3.6M | 8.7M | 3.8M |
Other Operating Expenses | 32.6M | 13.2M | 12.5M | 11.2M | 9.1M |
Total Operating Expenses | 32.6M | 19.2M | 16.1M | 19.9M | 12.9M |
Operating Income | -45.7M | -39.2M | -34.7M | -31.6M | -31.0M |
Operating Margin % | -4.1% | -7.7% | -235.4% | -258.5% | -372.2% |
Non-Operating Items | |||||
Interest Income | - | 21.9M | 23.5M | 163.6M | 20.1M |
Interest Expense | 13.2M | 0 | 0 | 0 | 0 |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 2.3M | 389.4M | 396.2M | 539.4M | 234.0M |
Income Tax | -515.0K | 3.3M | 4.0M | -6.7M | -10.5M |
Effective Tax Rate % | -22.7% | 0.8% | 1.0% | -1.2% | -4.5% |
Net Income | 2.8M | 386.1M | 392.3M | 546.0M | 244.5M |
Net Margin % | 0.2% | 76.2% | 2,665.0% | 4,469.1% | 2,936.4% |
Key Metrics | |||||
EBITDA | 23.0M | -42.4M | -40.7M | -48.1M | -44.0M |
EPS (Basic) | - | ₹5.55 | ₹5.64 | ₹7.85 | ₹3.52 |
EPS (Diluted) | - | ₹5.55 | ₹5.64 | ₹7.85 | ₹3.52 |
Basic Shares Outstanding | - | 69545849 | 69545849 | 69545849 | 69545849 |
Diluted Shares Outstanding | - | 69545849 | 69545849 | 69545849 | 69545849 |
Income Statement Trend
Uniphos Enterprises Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 120.8M | 29.9M | 15.0M | 16.3M | 43.2M |
Short-term Investments | 41.6M | 440.1M | 502.3M | 375.2M | 408.3M |
Accounts Receivable | 0 | 4.8M | 0 | 0 | - |
Inventory | - | - | - | - | - |
Other Current Assets | 267.0K | 149.0K | 171.0K | 221.0K | 792.0K |
Total Current Assets | 162.6M | 480.5M | 531.6M | 596.8M | 606.1M |
Non-Current Assets | |||||
Property, Plant & Equipment | - | 0 | 0 | 0 | 0 |
Goodwill | - | - | - | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | 28.3B | 20.3B | 30.4B | 32.4B | 27.1B |
Total Assets | 28.4B | 20.8B | 31.0B | 33.0B | 27.7B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 7.2M | 15.0M | 7.0M | 4.4M | 1.6M |
Short-term Debt | - | - | - | - | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 3.8M | 446.0K | 559.0K | 450.0K | 1.0M |
Total Current Liabilities | 18.4M | 20.5M | 10.6M | 6.0M | 2.6M |
Non-Current Liabilities | |||||
Long-term Debt | - | - | - | - | - |
Deferred Tax Liabilities | 982.2M | 0 | 968.1M | 1.2B | 566.4M |
Other Non-Current Liabilities | - | - | -2.0K | - | - |
Total Non-Current Liabilities | 982.2M | 0 | 968.1M | 1.2B | 566.4M |
Total Liabilities | 1.0B | 20.5M | 978.7M | 1.2B | 569.0M |
Equity | |||||
Common Stock | 139.1M | 139.1M | 139.1M | 139.1M | 139.1M |
Retained Earnings | - | 1.5B | 1.5B | 1.5B | 1.2B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 27.4B | 20.8B | 30.0B | 31.8B | 27.1B |
Key Metrics | |||||
Total Debt | 0 | 0 | 0 | 0 | 0 |
Working Capital | 144.2M | 460.0M | 521.0M | 590.8M | 603.5M |
Balance Sheet Composition
Uniphos Enterprises Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 2.3M | 389.4M | 396.2M | 539.4M | 234.0M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 10.4M | -4.9M | 159.0K | -12.0K | 254.0K |
Operating Cash Flow | 4.3M | 362.6M | 372.8M | 375.8M | 214.2M |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Acquisitions | - | - | - | - | - |
Investment Purchases | -2.0B | -528.1M | -452.0M | -739.6M | -890.1M |
Investment Sales | 2.5B | 601.9M | 387.0M | 390.0M | 300.0M |
Investing Cash Flow | 466.9M | 73.8M | -65.0M | -349.6M | -590.1M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -396.4M | -452.0M | -392.9M | -236.5M | - |
Debt Issuance | 400.0M | - | - | - | - |
Debt Repayment | -400.0M | - | - | - | - |
Financing Cash Flow | -396.4M | -452.0M | -392.9M | -236.5M | - |
Free Cash Flow | -27.2M | -34.7M | -14.7M | 5.2M | -45.9M |
Net Change in Cash | 74.8M | -15.7M | -85.1M | -210.2M | -376.0M |
Cash Flow Trend
Uniphos Enterprises Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
3,060.20
Price to Book
0.38
Price to Sales
9.33
Profitability Ratios
Profit Margin
-0.27%
Operating Margin
-17.10%
Return on Equity
0.01%
Return on Assets
0.01%
Financial Health
Current Ratio
8.83
Debt to Equity
0.00
Beta
0.28
Per Share Data
EPS (TTM)
₹0.05
Book Value per Share
₹400.22
Revenue per Share
₹16.84
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
unienter | 10.7B | 3,060.20 | 0.38 | 0.01% | -0.27% | 0.00 |
Navin Fluorine | 255.9B | 69.93 | 9.44 | 10.99% | 13.90% | 55.85 |
Deepak Nitrite | 253.2B | 41.67 | 4.70 | 11.85% | 7.58% | 23.36 |
India Glycols | 50.0B | 20.49 | 2.21 | 10.24% | 6.35% | 83.85 |
Styrenix Performance | 46.4B | 20.53 | 3.97 | 20.14% | 7.00% | 34.02 |
Gujarat Alkalies | 40.4B | 70.12 | 0.67 | -1.08% | -0.82% | 9.30 |
Financial data is updated regularly. All figures are in the company's reporting currency.